fda bpc-157 category 2 bulk drug substance compounding list Industry Update: Interim 503A and 503B Bulks Lists New Revisions FDA has removed certain bulk

FDA has removed certain bulk drug substances that were placed on the category two list and has announced it will consult the Pharmacy Compounding Advisory Committee (PCAC) for potential future inclusion of Exciting news for peptides coming out of today's committee hearing! The FDA Pharmacy Compounding Advisory Committee voted 8 6 to recommend adding BPC 157 to the 503A Bulks List for use in compounding for FDA panel votes to place popular peptide BPC 157 on compounding list Reuters Big news for peptides! In July, the FDA will meet to evaluate the most commonly used peptides for FDA authorized compounding. FDA Peptide Reclassification 2026: What It Means for Providers

SKU: 65110855325 · From creatorsinfotech.com